Reby Advisors’s Amgen AMGN Stock Holding History

Reby Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$89K	Buy	+386	New	+$89K	0.02%	156

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Reby Advisors's AMGN Position: Q4 2020 in Review

Reby Advisors opened a new position in Amgen (AMGN) in Q4 2020: 386 shares worth $89K. The stake represents 0.02% of the portfolio and ranks #156 among its holdings.

2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Reby Advisors held 386 shares of Amgen worth $89K as of Q4 2020.
Amgen was a new Reby Advisors position in Q4 2020.
Amgen made up 0.02% of Reby Advisors's portfolio in Q4 2020, its #156 holding.
2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.